Chris Langley

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.

David Rinaldi, Howard A. Burris, F. Andrew Dorr et al. · Journal of Clinical Oncology · 1995 · 152 citations

The corporatization of community pharmacy: Implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom

Joseph P. Bush, Chris Langley, Keith Wilson · Research in Social and Administrative Pharmacy · 2009 · 120 citations

Health Administration, Health Policy, Pharmaceutical Practice +7

An Analysis of Returned Medicines in Primary Care

Chris Langley, John Marriott, Adam Mackridge et al. · Pharmacy World & Science · 2005 · 58 citations

Family Medicine, Primary Care, Patient Safety +4

A qualitative study of English community pharmacists' experiences of providing lifestyle advice to patients with cardiovascular disease

Kirsty Morton, Helen Pattison, Chris Langley et al. · Research in Social and Administrative Pharmacy · 2014 · 48 citations · Full text

Novel Anti-bacterials Against MRSA: Synthesis of Focussed Combinatorial Libraries of Tri-Substituted 2(5H)-Furanones

Eric Lattmann, Nison Sattayasai, Carl Schwalbe et al. · Current Drug Discovery Technologies · 2006 · 46 citations

Combinatorial Chemistry, Organic Chemistry, Chemistry +17